Immune-mediated hemolytic anemia is a potentially fatal condition where the dog's immune system destroys its own red blood cells, requiring emergency treatment and close monitoring during a dangerous and unpredictable course.
IMHA causes acute, severe suffering from rapidly progressing anemia. Dogs experience profound weakness, breathlessness, and the physical distress of tissue oxygen deprivation. The rapid onset - dogs can deteriorate from apparently healthy to collapsed in hours - creates acute crises where every moment of delay in treatment worsens outcome. Blood transfusions provide temporary relief but the immune system attacks donor cells as well, limiting their effectiveness. The prolonged immunosuppressive treatment required - often months - causes its own welfare impacts including increased infection risk, muscle wasting, and behavioral changes. The high mortality rate means that owners often face devastating loss despite pursuing aggressive treatment. IMHA is unpredictable and terrifying for both dogs and their human families.